Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Feb 2;17(1):94.
doi: 10.1186/s12885-017-3086-y.

Cancer mortality in former East and West Germany: a story of unification?

Affiliations
Comparative Study

Cancer mortality in former East and West Germany: a story of unification?

Daniel Medenwald et al. BMC Cancer. .

Abstract

Background: Health and social conditions vary between West and East Germany.

Methods: We analyzed annual mortality data of all recorded deaths caused by lung, colorectal, breast and prostate cancer in Germany as they are published by the Federal Bureau of Statistics (FBS) encompassing the period 1980-2014 for former West Germany (WG) and 1990-2014 for former East Germany (EG). To compare East and West Germany we computed the ratio of the mortality rates in both parts (mortality rate ratio, MRR, <1 indicates a lower mortality in EG). Forecasting methods of time series analyses were applied (model selection based on the Box/Jenkins approach) to predict 5-year trends until 2019.

Results: Lung cancer: In women mortality rose in both regions (WG: +2.8%, 1991-2014, EG: +2.2%, 1990-2014). In men mortality in WG declined between -2.1% and -1.2%, and by -2.7% (1993-2009) in EG which was followed by a plateau. Colorectal cancer: A decline was found in both WG (-3.1%, 1993-2014) and EG women (-3.8%, 1993-2008 and -2.0%, 2008-2014). A decline in EG men since 1992 (-0.9%, 1992-1997 and -2.3%, 1997-2014) mirrors the development in WG (-2.6%, 1995-2014). Breast cancer: Constant mortality decline in WG after 1996. In EG a decline (-2.4%, 1992-2007) was followed by a plateau with an MRR <1 (1990-2014). Prostate cancer: In WG a decline (-3.4%) came to a hold after 2007, while there was a constant decline of 1.5% in EG. The forecast indicated that mortality of colorectal/lung cancer in men and breast cancer reaches a plateau in future years.

Conclusion: Courses of mortality were similar between East and West, while existing differences are likely to remain in the near future.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Time series of annual mortality rates for death from lung cancer in Germany. Black: East Germany; Grey: West Germany. Solid lines represent the estimates of the forecast with the respective 95% confidence intervals (dashed lines)
Fig. 2
Fig. 2
Ratio of annual mortality rates in East and West Germany for death from lung cancer in Germany. The mortality rate ratio was computed as the ratio of the annual age-standardized mortality in East Germany to that in West Germany
Fig. 3
Fig. 3
Time series of annual mortality rates for death from colorectal cancer in Germany. Black: East Germany; Grey: West Germany. Solid lines represent the estimates of the forecast with the respective 95% confidence intervals (dashed lines)
Fig. 4
Fig. 4
Ratio of annual mortality rates in East and West Germany for death from colorectal cancer in Germany. The mortality rate ratio was computed as the ratio of the annual age-standardized mortality in East Germany to that in West Germany
Fig. 5
Fig. 5
Time series of annual mortality rates for death from breast and prostate cancer in Germany. Black: East Germany; Grey: West Germany. Solid lines represent the estimates of the forecast with the respective 95% confidence intervals (dashed lines)
Fig. 6
Fig. 6
Ratio of annual mortality rates in East and West Germany for death from breast and prostate cancer in Germany. The mortality rate ratio was computed as the ratio of the annual age-standardized mortality in East Germany to that in West Germany

Similar articles

Cited by

References

    1. Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, La Vecchia C. Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980. Ann Oncol. 2013;24(10):2657–2671. doi: 10.1093/annonc/mdt301. - DOI - PubMed
    1. Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, Micheli A, Lillini R, Francisci S, Group E-W: Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51(15):2120–2129. - PubMed
    1. Quaglia A, Lillini R, Mamo C, Ivaldi E, Vercelli M, SEIH (Socio-Economic Indicators HaWG Socio-economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit Rev Oncol Hematol. 2013;85(3):266–277. doi: 10.1016/j.critrevonc.2012.08.007. - DOI - PubMed
    1. Lillini R, Vercelli M, Quaglia A, Micheli A, Capocaccia R. Use of socio-economic factors and healthcare resources to estimate cancer survival in European countries with partial national cancer registration. Tumori. 2011;97(3):265–274. - PubMed
    1. Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H, Group GCSW. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. 2012;27(9):689–693. doi: 10.1007/s10654-012-9723-5. - DOI - PubMed

Publication types